Atlas Trials

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

Clinical trial NCT01286038 · TERMINATED

Trial details

NCT number
NCT01286038
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndrome (MDS)Thrombocytopenia
Start date
2011-04-06
Primary completion
2017-11-03
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.